Cargando…

An online gene expression assay for determining adjuvant therapy eligibility in patients with stage 2 or 3 colon cancer

BACKGROUND: The decision whether to treat patients with non-metastatic colon cancer with adjuvant chemotherapy is determined by clinical staging, frequently resulting in over or undertreatment. METHODS: Gene expression data and clinical information from 232 stage 1–4 colon cancer patients were analy...

Descripción completa

Detalles Bibliográficos
Autor principal:	Van Laar, R K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2010
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008603/ https://www.ncbi.nlm.nih.gov/pubmed/21119668 http://dx.doi.org/10.1038/sj.bjc.6605970

Ejemplares similares

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
por: Bridgewater, J, et al.
Publicado: (2008)

Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX
por: Nehls, O, et al.
Publicado: (2007)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer
por: Patel, Meera, et al.
Publicado: (2018)

Development and validation of a plasma-based melanoma biomarker suitable for clinical use
por: Van Laar, Ryan, et al.
Publicado: (2018)

Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer
por: Michalski, C W, et al.
Publicado: (2008)

Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
por: Puppa, G, et al.
Publicado: (2007)

Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas
por: Mermelshtein, A, et al.
Publicado: (2005)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
por: Stotz, M, et al.
Publicado: (2014)

Activation of the PI3K/AKT pathway correlates with prognosis in stage II colon cancer
por: Malinowsky, K, et al.
Publicado: (2014)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014)

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
por: Zeestraten, E C M, et al.
Publicado: (2012)

Ectopic expression of the chemokine CXCL17 in colon cancer cells
por: Ohlsson, Lina, et al.
Publicado: (2016)

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
por: Absenger, G, et al.
Publicado: (2013)

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received
por: Dawson, S-J, et al.
Publicado: (2010)

Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status
por: Rego, R L, et al.
Publicado: (2010)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
por: Jubb, A M, et al.
Publicado: (2009)

Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome
por: Zhang, Y-Q, et al.
Publicado: (2012)

MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients
por: Pichler, M, et al.
Publicado: (2014)

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
por: Went, P, et al.
Publicado: (2006)

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
por: Langbein, S, et al.
Publicado: (2006)

Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells
por: Ueno, K, et al.
Publicado: (2009)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Prostaglandin E(2) stimulates Fas ligand expression via the EP1 receptor in colon cancer cells
por: O'Callaghan, G, et al.
Publicado: (2008)

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy
por: Maeda, J, et al.
Publicado: (2008)

Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer
por: Uno, K, et al.
Publicado: (2007)

Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma
por: Wangsa, D, et al.
Publicado: (2008)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse
por: Lu, C-Y, et al.
Publicado: (2011)

G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration
por: Morris, K T, et al.
Publicado: (2014)

Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study
por: Croner, R S, et al.
Publicado: (2014)

A loss of c-kit expression is associated with an advanced stage and poor prognosis in breast cancer
por: Tsutsui, S, et al.
Publicado: (2006)

NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy
por: Mozaffari, F, et al.
Publicado: (2007)

Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer
por: Angst, E, et al.
Publicado: (2006)

The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
por: Oladipo, O, et al.
Publicado: (2011)

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups
por: Sundquist, Elias, et al.
Publicado: (2017)

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
por: Ålgars, A, et al.
Publicado: (2011)

Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material
por: Gravendeel, L A M, et al.
Publicado: (2012)

Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB–IIA of cervical cancer
por: Beskow, C, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_dcnhgftg8hoqena6vfp5sjnkc8